Adirondack Trust Company’s Thermo Fisher Scientific TMO Stock Holding History

Adirondack Trust Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.1K	Buy	72 +3	+4%	+$1.44K	0.01%	294
2026 Q1	$33.9K	Sell	69 -12	-15%	-$6.51K	0.01%	291
2025 Q4	$46.9K	Buy	81 +16	+25%	+$9.05K	0.02%	254
2025 Q3	$31.5K	Hold	65	–	–	0.01%	301
2025 Q2	$26.4K	Sell	65 -20	-24%	-$8.36K	0.01%	296
2025 Q1	$42.3K	Hold	85	–	–	0.02%	249
2024 Q4	$44.2K	Hold	85	–	–	0.02%	252
2024 Q3	$52.6K	Hold	85	–	–	0.02%	241
2024 Q2	$47K	Sell	85 -10	-11%	-$5.73K	0.02%	246
2024 Q1	$55.2K	Hold	95	–	–	0.02%	234
2023 Q4	$54.2K	Sell	95 -359	-79%	-$174K	0.02%	228
2023 Q3	$230K	Hold	454	–	–	0.11%	120
2023 Q2	$249K	Buy	454 +101	+29%	+$54.5K	0.12%	122
2023 Q1	$203K	Hold	353	–	–	0.1%	132
2022 Q4	$194K	Buy	353 +4	+1%	+$2.12K	0.1%	133
2022 Q3	$177K	Buy	349 +287	+463%	+$161K	0.1%	130
2022 Q2	$34K	Buy	+62	New	+$34.1K	0.02%	214
2019 Q1	–	Sell	-20	Closed	-$4K	–	361
2018 Q4	$4K	Buy	+20	New	+$4.69K	﹤0.01%	300
2015 Q2	–	Sell	-65	Closed	-$9K	–	361
2015 Q1	$9K	Buy	+65	New	+$8.38K	0.01%	258

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Adirondack Trust Company's TMO Position: Q2 2026 in Review

Adirondack Trust Company increased its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, buying an estimated $1.44K and bringing the position to 72 shares worth $36.1K. The position accounts for 0.01% of the portfolio, ranked #294.

Adirondack Trust Company first reported a position in TMO in Q1 2015 and has held it in 19 quarters since. The position peaked at $249K in Q2 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Adirondack Trust Company held 72 shares of Thermo Fisher Scientific worth $36.1K as of Q2 2026.
Adirondack Trust Company bought 3 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.44K.
Thermo Fisher Scientific made up 0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #294 holding.
Adirondack Trust Company first reported a position in Thermo Fisher Scientific in Q1 2015 and has held it in 19 quarters since.
Adirondack Trust Company's Thermo Fisher Scientific position peaked at $249K in Q2 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.